On June 17-20, 2021, at the Third Annual Meeting of the Chinese Physicians Association of Vascular Surgery Physicians Branch, Prof. Luo Mingyao of Fu Wai Hospital, Chinese Academy of Medical Sciences, on behalf of Prof. Shu's team, gave a fascinating lecture on the progress of aortic disease treatment.

During the 13th Fuwai Symposium on the Treatment of Aortic Pathology, Professor Chen Ziying from the Department of Cardiac Macrovascular Surgery of the Second Hospital of Hebei Medical University shared the experience of hybridization surgery for type A aortic coarctation accumulated in their center.

Nowadays, cardiovascular diseases are becoming more and more complex, and the development of valve disease diagnosis and treatment means represented by TAVR marks the gradual end of the era of cardiovascular doctors "fighting alone", while the development of technology brings the unevenness of standardization and homogenization management. In the era of win-win cooperation, it is no longer the era of Zhao ZiLong fighting against a hundred and Xiang Yu killing a hundred, but the need for multidisciplinary teams to help each other and complement each other's strengths in dealing with complex cardiac pathologies, in order to bring patients the diagnosis and treatment effect of 1+1>2, and injecting new vitality and impetus into the development of the discipline.

At the 50th International Vascular and Endoluminal Vascular Congress (VEITH 2023), November 14-18, 2023, Professor Linda M. Harris from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, USA, shared gender differences in the clinical presentation of lower limb occlusive disease and intermittent claudication and the importance of the phenomenon.

At the 7th Vascular Innovation Forum (VINNOVA 2022), Prof. Kun Fang of Fu Wai Hospital, Chinese Academy of Medical Sciences (CAAMS), elaborated on the one-stop treatment strategy of composite surgery through two cases.